I  BM said Friday it will sell the core data assets of its Watson Health division to a San Francisco-based private equity firm, marking the staggering

Once billed as a revolution in medicine, IBM’s Watson Health is sold off in parts

submited by
Style Pass
2022-01-23 15:00:07

I BM said Friday it will sell the core data assets of its Watson Health division to a San Francisco-based private equity firm, marking the staggering collapse of its ambitious artificial intelligence effort that failed to live up to its promises to transform everything from drug discovery to cancer care.

Data and analytics assets held by the health business, which was not profitable, were sold to Francisco Partners as IBM seeks to refocus its business on cloud computing and AI services to help clients in multiple industries build machine learning tools and secure and manage their data. Terms of the transaction were not disclosed.

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

Casey covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. He is the co-author of the newsletter STAT Health Tech.

Leave a Comment